Coronavirus R&D Gateway

A World Trade Organisation waiver on intellectual property will not overcome immediate vaccine shortages. Compulsory licensing is a better approach

Member states have until the end of April to fine tune and adapt plans to fit with EU climate goals. But will bids to spend money on roads and gas pipelines support a green recovery?

Universities are caught in the cross fire of the pandemic. While the value of their research has never been more evident, the quality of online learning is questioned. How will university rankings respond? 

EU director of public health calls for better pandemic preparedness, as health commissioner tells Science|Business conference that vaccine rollout is ‘gathering pace’

Politicians should not overlook the role played by basic research in a year of rapid vaccine development, says Nobel prize winner and neuroscientist Edvard Moser

To boost infectious disease research post-pandemic, Europe should emulate the Crick’s dual approach of running basic research in parallel with translating discoveries to treatments, says Nobel prize winner Michael Houghton

This is the first call from the European Research Council under the new Horizon Europe research programme

As the problem of COVID-19 vaccines supplies so potently illustrates, it is time to rethink the EU’s pandemic preparedness strategy. More support is needed for late stage clinical development and large scale manufacturing